The potential to save the hearing of millions of people around the world

The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients

Related Keywords

Jian Zuo ,Jude Children Research Hospital ,World Health Organization ,Jude Children ,Research Hospital ,Experimental Medicine ,